191 related articles for article (PubMed ID: 10801172)
1. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.
Mourits MP; van Kempen-Harteveld ML; García MB; Koppeschaar HP; Tick L; Terwee CB
Lancet; 2000 Apr; 355(9214):1505-9. PubMed ID: 10801172
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.
Prummel MF; Terwee CB; Gerding MN; Baldeschi L; Mourits MP; Blank L; Dekker FW; Wiersinga WM
J Clin Endocrinol Metab; 2004 Jan; 89(1):15-20. PubMed ID: 14715820
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.
Johnson KT; Wittig A; Loesch C; Esser J; Sauerwein W; Eckstein AK
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):103-9. PubMed ID: 19865824
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
Kahaly GJ; Riedl M; König J; Pitz S; Ponto K; Diana T; Kampmann E; Kolbe E; Eckstein A; Moeller LC; Führer D; Salvi M; Curro N; Campi I; Covelli D; Leo M; Marinò M; Menconi F; Marcocci C; Bartalena L; Perros P; Wiersinga WM;
Lancet Diabetes Endocrinol; 2018 Apr; 6(4):287-298. PubMed ID: 29396246
[TBL] [Abstract][Full Text] [Related]
5. Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study.
van Geest RJ; Sasim IV; Koppeschaar HP; Kalmann R; Stravers SN; Bijlsma WR; Mourits MP
Eur J Endocrinol; 2008 Feb; 158(2):229-37. PubMed ID: 18230831
[TBL] [Abstract][Full Text] [Related]
6. Natural history of graves' orbitopathy after treatment.
Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
[TBL] [Abstract][Full Text] [Related]
7. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
[TBL] [Abstract][Full Text] [Related]
8. A treatment strategy for Graves' orbitopathy.
Marcocci C; Pinchera A; Marinò M
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
[TBL] [Abstract][Full Text] [Related]
9. Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial.
Lanzolla G; Sabini E; Leo M; Menconi F; Rocchi R; Sframeli A; Piaggi P; Nardi M; Marcocci C; Marinò M
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):733-742. PubMed ID: 34592164
[TBL] [Abstract][Full Text] [Related]
10. [Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results].
Pitz S; Kahaly G; Rösler HP; Krummenauer F; Wagner B; Stübler M; Pfeiffer N
Klin Monbl Augenheilkd; 2002 Dec; 219(12):876-82. PubMed ID: 12548473
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiotherapy for Graves' orbitopathy.
Heyd R; Strassmann G; Herkströter M; Martin T; Zamboglou N
Rontgenpraxis; 2001; 54(3):94-100. PubMed ID: 11799870
[TBL] [Abstract][Full Text] [Related]
12. Place of radiotherapy in the treatment of Graves' orbitopathy.
Beckendorf V; Maalouf T; George JL; Bey P; Leclere J; Luporsi E
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):805-15. PubMed ID: 10098436
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
[TBL] [Abstract][Full Text] [Related]
15. Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy.
Gerling J; Kommerell G; Henne K; Laubenberger J; Schulte-Mönting J; Fells P
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):182-9. PubMed ID: 12504052
[TBL] [Abstract][Full Text] [Related]
16. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy.
Baldeschi L; MacAndie K; Koetsier E; Blank LE; Wiersinga WM
Am J Ophthalmol; 2008 Mar; 145(3):534-540. PubMed ID: 18191092
[TBL] [Abstract][Full Text] [Related]
17. Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial.
Kahaly GJ; Rösler HP; Pitz S; Hommel G
J Clin Endocrinol Metab; 2000 Jan; 85(1):102-8. PubMed ID: 10634372
[TBL] [Abstract][Full Text] [Related]
18. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy.
Akmansu M; Dirican B; Bora H; Gurel O
Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842
[TBL] [Abstract][Full Text] [Related]
19. [Radiotherapy for Graves' ophthalmopathy].
Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
[TBL] [Abstract][Full Text] [Related]
20. Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
